Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF.
The item "Cash-Flow-Per-Share" stands at 22.54 Swiss Francs as of 06/30/2025.
As of the end of Roche Holding AG's second quarter, the item "Cash Flow Per Share" stands at 22.54 CHF. This represents a decrease of -5.60 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 14.06 percent compared to the value the year prior.
The 1 year change in percent is 14.06.
The 3 year change in percent is -45.01.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Cash Flow Per Share | 905,699,262,464.00 |
![]() | Johnson & Johnson - Cash Flow Per Share | 486,508,953,600.00 |
![]() | AbbVie Inc - Cash Flow Per Share | 399,570,305,024.00 |
![]() | AstraZeneca PLC - Cash Flow Per Share | 280,205,508,085.11 |
![]() | Novartis AG - Cash Flow Per Share | 255,096,620,580.91 |